Copyright
©2010 Baishideng Publishing Group Co.
World J Cardiol. Sep 26, 2010; 2(9): 299-304
Published online Sep 26, 2010. doi: 10.4330/wjc.v2.i9.299
Published online Sep 26, 2010. doi: 10.4330/wjc.v2.i9.299
Table 2 Different endothelial progenitor cell combinations stratified by outcomes n (%)
| Total mortality | Recurrent UA/MI | ADHF | Any MACE | |
| CD34+CD133+ = 0 (n = 7) | 1 (14.3) | 7 (100) | 1 (14.3) | 7 (100) |
| CD34+CD133+ > 0 (n = 69) | 6 (8.7) | 43 (62.3) | 12 (17.4) | 47 (68.1) |
| CD34+KDR+ = 0 (n = 57) | 6 (10.5) | 40 (70.2) | 11 (19.3) | 43 (75.4) |
| CD34+KDR+ > 0 (n = 17) | 1 (5.3) | 10 (52.6) | 2 (10.5) | 11 (57.9) |
| CD133+KDR+ = 0 (n = 57) | 6 (10.5) | 41 (71.9) | 12 (21.1) | 44 (77.2) |
| CD133+KDR+ > 0 (n = 19) | 1 (5.3) | 9 (47.4) | 1 (5.3) | 10 (52.6) |
- Citation: Schwartzenberg S, Afek A, Charach G, Rubinstein A, Ben-Shoshan Y, Kissil S, Maisel-Auslender S, Keren G, George J. Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome. World J Cardiol 2010; 2(9): 299-304
- URL: https://www.wjgnet.com/1949-8462/full/v2/i9/299.htm
- DOI: https://dx.doi.org/10.4330/wjc.v2.i9.299